Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database

被引：15

作者：

Dominguez-Valentin, Mev ^{[1
]}

Seppala, Toni T. ^{[2
,3
]}

Engel, Christoph ^{[4
]}

Aretz, Stefan ^{[5
,6
]}

Macrae, Finlay ^{[7
,8
]}

Winship, Ingrid ^{[7
,8
]}

Capella, Gabriel ^{[9
,10
]}

Thomas, Huw ^{[11
]}

Hovig, Eivind ^{[1
,12
]}

Nielsen, Maartje ^{[13
]}

Sijmons, Rolf H. ^{[14
]}

Bertario, Lucio ^{[15
]}

Bonanni, Bernardo ^{[16
]}

Tibiletti, Maria Grazia ^{[17
]}

Cavestro, Giulia Martina ^{[18
]}

Mints, Miriam ^{[19
]}

Gluck, Nathan ^{[20
,21
]}

Katz, Lior ^{[22
]}

Heinimann, Karl ^{[23
]}

Vaccaro, Carlos A. ^{[24
]}

Green, Kate ^{[25
,26
]}

Lalloo, Fiona ^{[25
,26
]}

Hill, James ^{[25
,27
]}

Schmiegel, Wolff ^{[28
]}

Vangala, Deepak ^{[29
]}

Perne, Claudia ^{[5
,6
]}

Strauss, Hans-Georg ^{[30
]}

Tecklenburg, Johanna ^{[31
]}

Holinski-Feder, Elke ^{[32
,33
]}

Steinke-Lange, Verena ^{[32
,33
]}

Mecklin, Jukka-Pekka ^{[34
,35
]}

Plazzer, John-Paul ^{[7
]}

Pineda, Marta ^{[9
,10
]}

Navarro, Matilde ^{[9
,10
]}

Vidal, Joan Brunet ^{[9
,10
]}

Kariv, Revital ^{[20
,21
]}

Rosner, Guy ^{[20
,21
]}

Alejandra Pinero, Tamara ^{[24
]}

Laura Gonzalez, Maria ^{[24
]}

Kalfayan, Pablo ^{[24
]}

Sampson, Julian R. ^{[36
]}

Ryan, Neil A. J. ^{[25
,26
]}

Evans, D. Gareth ^{[25
,26
]}

Moller, Pal ^{[1
]}

Crosbie, Emma J. ^{[25
,26
]}

机构：

[1] Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, N-0379 Oslo, Norway

[2] Univ Helsinki, Dept Abdominal Surg, Cent Hosp, Helsinki 00029, Finland

[3] Univ Helsinki, Fac Med, Helsinki 00014, Finland

[4] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04107 Leipzig, Germany

[5] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany

[6] Univ Hosp Bonn, Ctr Hereditary Tumor Syndromes, D-53127 Bonn, Germany

[7] Royal Melbourne Hosp, Colorectal Med & Genet, Melbourne, Vic 3052, Australia

[8] Univ Melbourne, Dept Med, Melbourne, Vic 3052, Australia

[9] Inst Invest Biomed Bellvitge IDIBELL, Catalan Inst Oncol, Hereditary Canc Program, ONCOBELL Program, Barcelona 08908, Spain

[10] Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain

[11] Imperial Coll London, Dept Surg & Canc, St Marks Hosp, London HA1 3UJ, England

[12] Univ Oslo, Ctr Bioinformat, Dept Informat, N-0316 Oslo, Norway

[13] Leids Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands

[14] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 GZ Groningen, Netherlands

[15] Fdn IRCCS Ist Nazl Tumori, European Inst Oncol, Div Prevent & Genet Oncol, I-20141 Milan, Italy

[16] European Inst Oncol, Div Prevent & Genet Oncol, I-20141 Milan, Italy

[17] Univ Insubria, Osped Circolo ASST Settelaghi, Ctr Ric Tumori Eredo Familiari, I-21100 Varese, Italy

[18] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Gastroenterol & Gastrointestinal Endoscopy Unit, I-20132 Milan, Italy

[19] Karolinska Inst, S-17176 Stockholm, Sweden

[20] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol, IL-64239 Tel Aviv, Israel

[21] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel

[22] Hadassah Med Ctr, Dept Gastroenterol & Hepatol, IL-91120 Jerusalem, Israel

[23] Univ Hosp Basel, Inst Med Genet & Pathol, Med Genet, CH-4031 Basel, Switzerland

[24] Hosp Italiano Buenos Aires, Hereditary Canc Program PROCANHE, C1199ABB, Buenos Aires, DF, Argentina

[25] Univ Manchester, Manchester M13 9WL, Lancs, England

[26] Manchester Univ NHS Fdn Trust, Manchester M13 9WL, Lancs, England

[27] Manchester Univ NHS Fdn Trust, Dept Surg, Manchester M13 9WL, Lancs, England

[28] Ruhr Univ Bochum, Dept Med, Knappschaftskrankenhaus, D-44801 Bochum, Germany

[29] Ruhr Univ Bochum, Dept Med, Knappschaftskrankenhaus, D-44892 Bochum, Germany

[30] Martin Luther Univ Halle Wittenberg, Univ Clin, Dept Gynecol, D-06097 Halle, Saale, Germany

[31] Hannover Med Sch, Inst Human Genet, D-30625 Hannover, Germany

[32] Klinikum Univ Munchen, Med Klin & Poliklin 4, Campus Innenstadt, D-80336 Munich, Germany

[33] MGZ Med Genet Ctr, D-80335 Munich, Germany

[34] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla 40014, Finland

[35] Cent Finland Hlth Care Dist, Dept Surg, Jyvaskyla 40620, Finland

[36] Cardiff Univ, Sch Med, Div Canc & Genet, Inst Med Genet, Cardiff CF14 4XN, Wales

来源：

JOURNAL OF CLINICAL MEDICINE | 2020年 / 9卷 / 07期

关键词：

Lynch syndrome; endometrial cancer; ovarian cancer; risk-reducing surgery; HORMONE REPLACEMENT THERAPY; COLORECTAL-CANCER; HEALTH; ESTROGEN;

D O I：

10.3390/jcm9072290

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and advice regarding hormone replacement therapy (HRT) in women with Lynch syndrome. Methods: We conducted a survey in 31 contributing centers from the Prospective Lynch Syndrome Database (PLSD), which incorporates 18 countries worldwide. The survey covered local policies for risk-reducing hysterectomy and BSO in Lynch syndrome, the timing when these measures are offered, the involvement of stakeholders and advice regarding HRT. Results: Risk-reducing hysterectomy and BSO are offered to path_MLH1 and path_MSH2 carriers in 20/21 (95%) contributing centers, to path_MSH6 carriers in 19/21 (91%) and to path_PMS2 carriers in 14/21 (67%). Regarding the involvement of stakeholders, there is global agreement (similar to 90%) that risk-reducing surgery should be offered to women, and that this discussion may involve gynecologists, genetic counselors and/or medical geneticists. Prescription of estrogen-only HRT is offered by 15/21 (71%) centers to women of variable age range (35-55 years). Conclusions: Most centers offer risk-reducing gynecological surgery to carriers of path_MLH1, path_MSH2 and path_MSH6 variants but less so for path_PMS2 carriers. There is wide variation in how, when and to whom this is offered. The Manchester International Consensus Group developed recommendations to harmonize clinical practice across centers, but there is a clear need for more research.

引用

页码：1 / 8

页数：8

共 50 条

[31] Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic
Patrícia Koehler-Santos
Patricia Izetti
Jamile Abud
Carlos Eduardo Pitroski
Silvia Liliana Cossio
Suzi Alves Camey
Cláudio Tarta
Daniel C Damin
Paulo Carvalho Contu
Mario Antonello Rosito
Patricia Ashton-Prolla
Joāo Carlos Prolla
World Journal of Gastroenterology, 2011, 17 (06) : 766 - 773
[32] The Potential for Reducing Lynch Syndrome Cancer Risk with Nutritional Nrf2 Activators
Aussem, Andrew
Ludwig, Kirsten
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2021, 73 (03): : 404 - 419
[33] Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome
Modaffari, Paola
Ponzone, Riccardo
Ferrari, Alberta
Cipullo, Isabella
Liberale, Viola
D'Alonzo, Marta
Maggiorotto, Furio
Biglia, Nicoletta
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (03):
[34] Mullerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery
Casey, Murray Joseph
Colanta, Agnes B.
FAMILIAL CANCER, 2016, 15 (03) : 371 - 384
[35] The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care
Pål Møller
Hereditary Cancer in Clinical Practice, 18
[36] Metachronous colon cancer risk following surgery for first primary rectal cancer in Lynch syndrome
S Parry
AK Win
B Parry
M Kalady
FA Macrae
NM Lindor
RW Haile
PA Newcomb
L Le Marchand
S Gallinger
JL Hopper
MA Jenkins
Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
[37] Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Dominguez-Valentin, Mev
Sampson, Julian R.
Seppala, Toni T.
ten Broeke, Sanne W.
Plazzer, John-Paul
Nakken, Sigve
Engel, Christoph
Aretz, Stefan
Jenkins, Mark A.
Sunde, Lone
Bernstein, Inge
Capella, Gabriel
Balaguer, Francesc
Thomas, Huw
Evans, D. Gareth
Burn, John
Greenblatt, Marc
Hovig, Eivind
de Vos Tot Nederveen Cappel, Wouter H.
Sijmons, Rolf H.
Bertario, Lucio
Tibiletti, Maria Grazia
Cavestro, Giulia Martina
Lindblom, Annika
Della Valle, Adriana
Lopez-Kostner, Francisco
Gluck, Nathan
Katz, Lior H.
Heinimann, Karl
Vaccaro, Carlos A.
Buettner, Reinhard
Goergens, Heike
Holinski-Feder, Elke
Morak, Monika
Holzapfel, Stefanie
Hueneburg, Robert
von Knebel Doeberitz, Magnus
Loeffler, Markus
Rahner, Nils
Schackert, Hans K.
Steinke-Lange, Verena
Schmiegel, Wolff
Vangala, Deepak
Pylvanainen, Kirsi
Renkonen-Sinisalo, Laura
Hopper, John L.
Win, Aung Ko
Haile, Robert W.
Lindor, Noralane M.
Gallinger, Steven
GENETICS IN MEDICINE, 2020, 22 (01) : 15 - 25
[38] Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives
Hunter, Jessica Ezzell
Arnold, Kathleen A.
Cook, Jennifer E.
Zepp, Jamilyn
Gilmore, Marian J.
Rope, Alan F.
Davis, James V.
Bergen, Kellene M.
Esterberg, Elizabeth
Muessig, Kristin R.
Peterson, Susan K.
Syngal, Sapna
Acheson, Louise
Wiesner, Georgia
Reiss, Jacob
Goddard, Katrina A. B.
FAMILIAL CANCER, 2017, 16 (03) : 377 - 387
[39] Low Rates of Genetic Counseling and Testing in Individuals at Risk for Lynch Syndrome Reported in the National Health Interview Survey
Faust, Nolan
Muller, Charles
Prenner, Joshua
Lee, Sang Mee
Kupfer, Sonia S.
GASTROENTEROLOGY, 2020, 158 (04) : 1159 - 1161
[40] Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives
Jessica Ezzell Hunter
Kathleen A. Arnold
Jennifer E. Cook
Jamilyn Zepp
Marian J. Gilmore
Alan F. Rope
James V. Davis
Kellene M. Bergen
Elizabeth Esterberg
Kristin R. Muessig
Susan K. Peterson
Sapna Syngal
Louise Acheson
Georgia Wiesner
Jacob Reiss
Katrina A. B. Goddard
Familial Cancer, 2017, 16 : 377 - 387

← 1 2 3 4 5 →